Background
- The androgen receptor (AR) is a hormone-regulated transcription factor that plays an important role in breast cancer (BC) pathogenesis.
- While estrogen receptor inhibitors are well-studied in BC, the role of AR on prognosis and therapy is less well-known.
- Here we aim to characterize the clinicopathologic and molecular features of AR expression in BC.